[1] Galie N, Humbert M, Vachiery JL, et al.  2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2016, 37(1): 67-119.   doi: 10.1093/eurheartj/ehv317
[2] Ohira H, deKemp R, Pena E, et al.  Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(12): 1424-1431.   doi: 10.1093/ehjci/jev136
[3] Shrestha U, Sciammarella M, Alhassen F, et al.  Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and 99mTc-tetrofosmin: method and validation[J]. J Nucl Cardiol, 2017, 24(1): 268-277.   doi: 10.1007/s12350-015-0320-3
[4] Saygin D, Highland KB, Farha S, et al.  Metabolic and functional evaluation of the heart and lungs in pulmonary hypertension by gated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography[J]. Pulm Circ, 2017, 7(2): 428-438.   doi: 10.1177/2045893217701917
[5] Fang W, Zhao L, Xiong CM, et al.  Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease[J]. Pulm Circ, 2012, 2(3): 365-372.   doi: 10.4103/2045-8932.101651
[6] Wang L, Li W, Yang Y, et al.  Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study[J]. Euro Heart J Cardiovasc Imaging, 2016, 17(10): 1161-1168.   doi: 10.1093/ehjci/jev297
[7] Yan CW, Pan XB, Wan LY, et al.  Combination of F-ASO and targeted medical therapy in patients with secundum ASD and severe PAH[J]. JACC Cardiovasc Interv, 2020, 13(17): 2024-2034.   doi: 10.1016/j.jcin.2020.04.027
[8] Vonk-Noordegraaf A, Haddad F, Chin KM, et al.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology[J]. J Am Coll Cardiol, 2013, 62(25 Suppl): SD22-D33.   doi: 10.1016/j.jacc.2013.10.027
[9] Graham BB, Kumar R, Mickael C, et al.  Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(5): L435-L440.   doi: 10.1152/ajplung.00169.2015
[10] Marsboom G, Wietholt C, Haney CR, et al.  Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2012, 185(6): 670-679.   doi: 10.1164/rccm.201108-1562OC
[11] Oikawa M, Kagaya Y, Otani H, et al.  Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol[J]. J Am Coll Cardiol, 2005, 45(11): 1849-1855.   doi: 10.1016/j.jacc.2005.02.065
[12] Kazimierczyk R, Szumowski P, Nekolla SG, et al.  Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension[J]. Heart, 2021, 107(1): 54-60.   doi: 10.1136/heartjnl-2020-316741
[13] Tatebe S, Fukumoto Y, Oikawa-Wakayama M, et al.  Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study[J]. Eur Heart J Cardiovasc Imaging, 2014, 15(6): 666-672.   doi: 10.1093/ehjci/jet276
[14] Yang T, Wang L, Xiong CM, et al.  The ratio of 18F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function[J]. Clin Nucl Med, 2014, 39(5): 426-430.   doi: 10.1097/RLU.0000000000000422
[15] Can MM, Kaymaz C, Tanboga IH, et al.  Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension[J]. Clin Nucl Med, 2011, 36(9): 743-748.   doi: 10.1097/RLU.0b013e3182177389